Kidney Failure Treatment Options: Dialysis, Transplant, and Conservative Care

Chronic kidney disease (CKD) impairs the kidneys’ ability to filter blood. The Centers for Disease Control and Prevention (CDC) estimates that about 37 million Americans—roughly 15 % of the U.S. population—live with CKD.

Below is an overview of the main treatment pathways for kidney failure, including their benefits, risks, and typical outcomes.

Hemodialysis

Hemodialysis uses a machine to remove waste products and excess fluid from the bloodstream. It also helps control blood pressure and mineral balance.

Before starting, a minor surgical procedure creates a vascular access point—usually in the arm—so blood can be drawn out, filtered, and returned during each session.

During treatment, blood flows through a dialyzer (the filter) and is then returned to the body. Most patients undergo three sessions per week, each lasting about four hours, either at a dialysis center or at home.

Hemodialysis may not be feasible if reliable vascular access is impossible or if blood‑pressure stability is a concern.

Potential side effects and risks include infection at the access site, low blood pressure, muscle cramps, and fatigue.

Peritoneal Dialysis

Peritoneal dialysis filters blood inside the body using the peritoneum—the membrane lining the abdominal cavity—as a natural filter. The procedure is performed at home.

A soft catheter is surgically placed in the abdomen. A dialysis solution (mostly water and electrolytes) is introduced through the catheter, drawing waste and excess fluid across the peritoneal membrane. After a few hours, the used solution is drained.

Patients with abdominal abnormalities (e.g., fistulas, adhesions, hernias), severe obesity, or inflammatory bowel disease may be unsuitable candidates.

Potential side effects and risks include catheter infection (peritonitis), abdominal discomfort, and loss of protein in the drained fluid.

Kidney Transplant

A transplant replaces the failing organ with a healthy kidney from a living or deceased donor. One functioning kidney can sustain normal life.

Transplant surgery is major and requires lifelong immunosuppressive medication to prevent rejection. Not all patients are eligible—advanced age, significant comorbidities, or certain medical conditions (e.g., active cancer, uncontrolled infection) may preclude transplantation.

Eligible candidates are placed on a national waiting list; typical wait times range from four to five years. While waiting, dialysis remains the primary therapy.

Possible complications include bleeding, blood clots, infection, urine leakage, cardiovascular events, ureteral obstruction, drug‑related side effects, certain cancers (e.g., melanoma, Kaposi sarcoma), and graft rejection.

Medications and Symptom Management

No drug can reverse kidney failure, but medications can alleviate symptoms and address complications such as anemia, bone disease, high blood pressure, and electrolyte imbalances.

Therapeutic classes often used include erythropoiesis‑stimulating agents, phosphate binders, vitamin D analogues, antihypertensives, and diuretics.

Conservative Management

Some patients opt for a non‑dialysis approach that focuses on medication, dietary modification, and close monitoring. While it does not replace kidney function, it can improve quality of life and delay the need for more aggressive interventions.

Can kidney damage be repaired?

Unfortunately, damaged kidney tissue cannot be regenerated. Treatment aims to slow progression and manage complications.

Can you treat kidney failure without dialysis?

A transplant is the only definitive alternative to lifelong dialysis, but due to donor scarcity many patients remain on dialysis while awaiting an organ. Conservative management offers symptom relief without dialysis but does not restore filtration.

How long can a person live with kidney failure?

Life expectancy varies with age, overall health, and chosen therapy. The National Kidney Foundation reports an average survival of 5–10 years for dialysis patients, while a 2021 study found a median post‑transplant survival of 14.6 years. Survival under conservative management ranges widely—from about 1 month to 41 months—according to a 2022 systematic review.

Each treatment option carries distinct advantages and risks. Discuss these thoroughly with your nephrology team to determine the best individualized plan.